Glomerular Endothelial Cell Injury and Focal Segmental Glomerulosclerosis Lesion in Idiopathic Membranous Nephropathy

Background Focal segmental glomerulosclerosis (FSGS) lesions have often been discussed as a negative predictor in idopathic membranous nephropathy (MN). The mechanism of the development of FSGS lesion in MN is still uncertain. Methods From 250 cases of MN, 26 cases contained FSGS lesion. We compared the clinicopathological characteristics between MN cases with FSGS lesion [MN-FSGS(+)] and MN without FSGS lesion [MN-FSGS(−)], matched for gender, age, stage of MN. Results The glomerular filtration rate (eGFR) was significantly lower in MN-FSGS(+) cases compared to MN-FSGS(−), although nephrotic syndrome, hematuria, and systolic blood pressure levels were not significantly different between the two groups. Pathologically, glomeruli in MN-FSGS(+) cases showed narrowing and loss of glomerular capillaries with separating from GBM or disappearance of CD34+ endothelial cells, and accumulation of extracellular matrix (ECM) in capillary walls, indicating the development of glomerular capillary injury. These findings of endothelial injury were seen even in MN-FSGS(−) cases, but they were more prominent in MN-FSGS(+) than MN-FSGS(−) by computer assessed morphometric analysis. In MN-FSGS(+) cases, 44 out of 534 glomeruli (8.2%) contained FSGS lesions (n = 31, NOS lesion; n = 13, perihilar lesion). Significant thickness of GBM with ECM accumulation was evident in MN-FSGS(+) cases. Podocyte injury with effacement of foot processes was also noted, but the expression of VEGF on podocytes was not different between the two groups, which suggests that the significant thickness of capillary walls may influence the function of VEGF from podocyte resulting in the glomerular capillary injury that contribute to the development of FSGS lesion in MN. Conclusion Glomerular capillary injury was seen in all MN cases. Furthermore, the prominent injuries of glomerular capillaries may be associated with the deterioration of eGFR and the formation of FSGS lesions in MN.

[1]  L. Castellano,et al.  An Overview of Molecular Mechanism of Nephrotic Syndrome , 2012, International journal of nephrology.

[2]  W. Min,et al.  Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling. , 2010, Journal of the American Society of Nephrology : JASN.

[3]  M. Hara,et al.  Podocyte membrane vesicles in urine originate from tip vesiculation of podocyte microvilli. , 2010, Human pathology.

[4]  G. Fernández-Juárez,et al.  Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. , 2010, Journal of the American Society of Nephrology : JASN.

[5]  S. Agarwal,et al.  Focal segmental glomerulosclerosis in idiopathic membranous glomerulonephritis: a clinico-pathological and stereological study. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  N. Hirankarn,et al.  Decreased renal expression of vascular endothelial growth factor in lupus nephritis is associated with worse prognosis. , 2009, Kidney international.

[7]  D. Nochy,et al.  VEGF inhibition and renal thrombotic microangiopathy. , 2008, The New England journal of medicine.

[8]  U. Specks,et al.  Idiopathic membranous nephropathy: diagnosis and treatment. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[9]  C. Alpers,et al.  VEGF inhibition and renal thrombotic microangiopathy. , 2008, The New England journal of medicine.

[10]  J. Deegens,et al.  Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  H. Schnaper,et al.  A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[12]  D. Cattran,et al.  Renal pathology in idiopathic membranous nephropathy: a new perspective. , 2006, Kidney international.

[13]  T. Kajita,et al.  Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury. , 2005, Journal of the American Society of Nephrology : JASN.

[14]  A. Flyvbjerg,et al.  The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. , 2004, Kidney international.

[15]  N. Yorioka,et al.  Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. , 2004, Kidney international.

[16]  Agnes B Fogo,et al.  Pathologic classification of focal segmental glomerulosclerosis: a working proposal. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  M. Ruutu,et al.  Decreased expression of vascular endothelial growth factor in idiopathic membranous glomerulonephritis: relationships to clinical course. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  M. Hughson,et al.  Glomerular size and glomerulosclerosis: relationships to disease categories, glomerular solidification, and ischemic obsolescence. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  M. Hara,et al.  Urinary Podocytes in Primary Focal Segmental Glomerulosclerosis , 2001, Nephron.

[20]  A. Teppo,et al.  Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis. , 2000, Kidney international.

[21]  T. Nishino,et al.  Glomerular hypertrophy in preeclamptic patients with focal segmental glomerulosclerosis. A morphometric analysis. , 1999, Clinical nephrology.

[22]  M. Haas,et al.  Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  C. Ponticelli,et al.  Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications. , 1997, Kidney international.

[24]  K. Shulman,et al.  Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases. , 1996, Journal of the American Society of Nephrology : JASN.

[25]  D. Heudes,et al.  Preeclampsia associated focal and segmental glomerulosclerosis and glomerular hypertrophy: a morphometric analysis. , 1994, Clinical nephrology.

[26]  G. Remuzzi,et al.  Prognosis of untreated patients with idiopathic membranous nephropathy , 1993, Pediatric Nephrology.

[27]  A. Magil,et al.  Focal glomerulosclerosis in idiopathic membranous glomerulonephritis. , 1992, Kidney international.

[28]  V. Desmet,et al.  Adhesions, focal sclerosis, protein crescents, and capsular lesions in membranous nephropathy , 1990, The Journal of pathology.

[29]  F. Velásquez Forero,et al.  [Idiopathic membranous glomerulonephritis]. , 1979, Boletin medico del Hospital Infantil de Mexico.

[30]  T. Taguchi,et al.  [Pathology of membranous nephropathy]. , 2011, Nihon Jinzo Gakkai shi.

[31]  S. Goshima,et al.  Pathologic findings of initial biopsies reflect the outcomes of membranous nephropathy. , 2004, Kidney international.

[32]  G. Hill,et al.  Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[33]  J. Wetzels,et al.  Prognostic factors in idiopathic membranous nephropathy. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  H. Lee,et al.  Nature of progressive glomerulosclerosis in human membranous nephropathy. , 1993, Clinical nephrology.

[35]  Y. Pei,et al.  Predicting progression in membranous glomerulonephritis. , 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.